➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
McKesson
McKinsey
Baxter
Mallinckrodt

Last Updated: October 23, 2021

DrugPatentWatch Database Preview

Torsemide - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic drug sources for torsemide and what is the scope of patent protection?

Torsemide is the generic ingredient in three branded drugs marketed by Roche, Am Regent, West-ward Pharms Int, Mylan Speciality Lp, Sarfe Pharms, Aurobindo Pharma, Corepharma, Hetero Labs Ltd Iii, Hikma Pharms, Par Pharm, Pliva Pharm Ind, Sun Pharm Inds, Teva, and Vintage Pharms, and is included in fourteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Torsemide has two patent family members in two countries.

There are sixteen drug master file entries for torsemide. Fourteen suppliers are listed for this compound.

Drug Prices for torsemide

See drug prices for torsemide

Drug Sales Revenue Trends for torsemide

See drug sales revenues for torsemide

Recent Clinical Trials for torsemide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assiut UniversityPhase 4
National Heart, Lung, and Blood Institute (NHLBI)Phase 4
Duke UniversityPhase 4

See all torsemide clinical trials

Pharmacology for torsemide
Paragraph IV (Patent) Challenges for TORSEMIDE
Tradename Dosage Ingredient NDA Submissiondate
DEMADEX TABLET;ORAL torsemide 020136

US Patents and Regulatory Information for torsemide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds TORSEMIDE torsemide TABLET;ORAL 078478-001 Feb 26, 2008 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Hetero Labs Ltd Iii TORSEMIDE torsemide TABLET;ORAL 079234-002 Jan 27, 2009 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Hikma Pharms TORSEMIDE torsemide TABLET;ORAL 076943-001 Mar 1, 2005 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-001 Aug 23, 1993 DISCN Yes No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Am Regent TORSEMIDE torsemide INJECTABLE;INJECTION 090656-001 Apr 21, 2010 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for torsemide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche DEMADEX torsemide INJECTABLE;INJECTION 020137-002 Aug 23, 1993 ⤷  Try it Free ⤷  Try it Free
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-003 Aug 23, 1993 ⤷  Try it Free ⤷  Try it Free
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-003 Aug 23, 1993 ⤷  Try it Free ⤷  Try it Free
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-002 Aug 23, 1993 ⤷  Try it Free ⤷  Try it Free
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-004 Aug 23, 1993 ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
McKesson
McKinsey
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.